REVO Oncology Diagnostics Inc., 2026-04-13
An SEC Form D private-offering notice from Frisco, TX, a $1,200,000 filer-stated offering target in Biotech. Filed 2026-04-13. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Developer of Chemo Select, a genomic platform that predicts which chemotherapies a cancer patient will respond to before treatment begins.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Source Donor Inc., 2026-04-16, $63.1M, Austin, TX
- Watershed Medical Inc., 2026-04-14, $10M, Bellevue, WA
- TAVRA BIOSCIENCES LLC, 2026-04-15, $2M, Plano, TX
- GreenMark Biomedical Inc., 2026-04-14, $5M, East Lansing, MI
- Moovalot, LLC, 2026-04-15, $500K, Houston, TX
- Canal Biosciences, Inc., 2026-04-13, $3.2M, Lowell, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.